High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for Adult T cell leukemia

Journal of Medical Virology

Volumn 83, Issue 4, 2011, Pages 702-709

  Ogata, Masao ^a,b   Satou, Takako ^b   Kawano, Rie ^b   Yoshikawa, Tetsushi ^c   Ikewaki, Junji ^b   Kohno, Kazuhiro ^b   Ando, Takeaki ^b   Miyazaki, Yasuhiko ^d   Ohtsuka, Eiichi ^d   Saburi, Yoshio ^d   Kikuchi, Hiroshi ^e   Saikawa, Tetsunori ^a   Kadota, Jun ichi ^b  

^a OITA UNIVERSITY HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OITA PREFECTURAL HOSPITAL   (Japan)

^e National Hospital Organization Nishibeppu National Hospital   (Japan)

Author keywords

ATL; CMV; EBV; HHV 6; Real time PCR

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PIRARUBICIN; PREDNISOLONE; VINCRISTINE; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; INCIDENCE; KINETICS; MALE; REAL TIME POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; VIRUS REACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG THERAPY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; INCIDENCE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; ROSEOLOVIRUS INFECTIONS; VIRUS ACTIVATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6;

EID: 79951532169     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22013     Document Type: Article

References (34)

1. Boeckh M, Ljungman P. 2009. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113: 5711-5719.
2. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. 1996. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study. Blood 88: 4063-5719.
3. Chen S, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC, Soroosh P, Tada K, Harigae H, Kameoka J, Kasai N, Sakaki T, Sugamura K. 2006. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol 18: 269-277.
4. Fujiwara H, Matsumoto T, Eizuru Y, Matsushita K, Ohtsubo H, Kukita T, Imaizumi R, Matumoto M, Hidaka S, Arima N, Tei C. 2000. Cytomegalovirus infection is not necessarily a poor prognostic factor in adult T-cell leukemia/lymphoma. J Med Virol 62: 140-143.
5. Fujiwara H, Eizuru Y, Matsumoto T, Kukita T, Imaizumi R, Kawada H, Ohtsubo H, Matsushita K, Arima N, Tei C. 2001. The significance of cytomegalovirus infection over the clinical course of adult T-cell leukemia/lymphoma. Microbiol Immunol 45: 97-100.
6. Han XY. 2007. Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer. J Clin Micrbiol 45: 1126-1132.
7. Idutsu K, Abe Y, Otonari J, Tachikawa Y, Ohtsuka R, Choi I, Muta K, Takayanagi R. 2007. Human herpesvirus 6 encephalitis in a patient with adult T-cell leukemia/lymphoma. Rinsho Ketsueki 48: 664-666 [article in Japanese].
8. Ikewaki J, Ohtsuka E, Satou T, Kawano R, Ogata M, Kikuchi H, Nasu M. 2005. Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation. Bone Marrow Transplant 35: 403-410.
9. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. 1999. Quantitative analysis of Epstein-Barr virus by using a real-time PCR assay. J Clin Microbiol 37: 132-136.
10. Ljungman P. 2010. Molecular monitoring of viral infections after hematopoietic stem cell transplantation. Int J Hematol 91: 596-601.
11. Locatelli G, Santoro F, Veglia F, Gobbi A, Lusso P, Malnati MS. 2000. Real-time quantitative PCR for human herpesvirus 6 DNA. Clin Microbiol 38: 4042-4048.
12. Meerbach A, Wutzler P, Hafer R, Zintl F, Gruhn B. 2008. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease. J Med Virol 80: 441-454.
13. Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, Whimbey E. 2001. Cytomegalovirus pneumonia in adults with leukemia: An emerging problem. Clin Infect Dis 21: 539-545.
14. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K, Kashima K, Ohtsuka E, Kadota J. 2006. Human herpesvirus 6 DNA load in plasma after allogeneic stem cell transplantation: Incidence and clinical significance. J Infect Dis 193: 68-79.
15. Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, Kohno K, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota J. 2008. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: A prospective evaluation. Bone Marrow Transplant 41: 279-285.
16. Ogata M, Satou T, Kawano R, Takakura S, Goto K, Ikewaki J, Kohno K, Ikebe T, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota J. 2010. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 45: 129-136.
17. Ohshima K, Suzumiya J, Kato A, Tashiro K, Kikuchi M. 1997. Clonal HTLV-1-infected CD4+ T-lymphocytes and non-clonal non-HTLV-1-infected giant cells in incipient ATLL with Hodgkin-like histologic features. Int J Cancer 72: 592-598.
18. Omar H, Hagglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringden O, Sparelid E, Sudnin M, Winiarski J, Yun Z, Ljungman P. 2009. Target monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis 11: 393-399.
19. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, Cohen JI, Young NS, John Barrett A. 2007. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 109: 3219-3224.
20. Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE. 1999. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 68: 1851-1854.
21. Shimoyama M. 1991. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79: 428-437.
22. Suzumiya J, Marutsuka K, Nabeshima K, Nawa Y, Koono M, Tamura K, Kimura N, Hisano S, Tachibana N, Inoue S, Sumiyoshi A. 1993. Autopsy findings in 47 cases of adult T-cell leukemia/lymphoma in Miyazaki prefecture, Japan. Leuk Lymphoma 11: 281-286.
23. Takeda N, Isonuma H, Sekiya S, Ebe T, Matsumoto T, Watanabe K. 2001. Studies of anti-cytomegalovirus IgG antibody positive rate and cytomegalovirus mononucleosis in adults. Kansenshogaku Zasshi 75: 775-779 [article in Japanese].
24. Tanaka Y, Kondo T, Kishimoto W, Kanda J, Tashima M, Mizumoto C, Icinohe T, Ishikawa T, Uchiyama T, Haga H, Manabe T. 2008. Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T cell leukemia. Rinsho Ketsueki 49: 263-269 [article in Japanese].
25. Tobinai K, Ohtsu T, Hayashi M, Kinoshita T, Matsuno Y, Mukai K, Shimoyama M. 1991. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T cell leukemia-lymphoma. Leuk Res 15: 837-846.
26. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H, Ueda R, Tamura K, Sano M, Momita S, Yamaguchi K, Kawano F, Hanada S, Tobinai K, Shimoyama M, Hotta T, Tomonaga M. 2007. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25: 5458-5464.
27. Uchiyama T. 1997. Human T cell leukemia virus type 1 (HTLV-1) and human diseases. Annu Rev Immunol 15: 15-37.
28. van Brussel M, Salemi M, Liu HF, Goubau P, Desmyter J, Vandamme AM. 1999. The discovery of two new divergent STLVs has implications for the evolution and epidemiology of HTLVs. Rev Med Virol 9: 155-170.
29. Yasunaga J, Sakai T, Nosaka K, Etoh Ki, Tamiya S, Koga S, Mita S, Uchino M, Mitsuya H, Matsuoka M. 2001. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: Its implications in the immunodeficient state. Blood 97: 3177-3183.
30. Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S, Kudo K, Horibe K, Kojima S, Kato K, Matsuyama T, Nishiyama Y. 2002. Human herpesvirus 6 viremia in bone marrow transplant recipients: Clinical features and risk factors. J Infect Dis 185: 847-853.
31. Zerr DM. 2006a. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 37: 52-56.
32. Zerr DM. 2006b. Human herpesvirus 6: A clinical update. Herpes 13: 20-24.
33. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, Rhoads MP, Nguy L, Bornemann R, Morrow RA, Corey L. 2005a. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352: 768-776.
34. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. 2005b. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40: 932-940.